Ceryvyn Therapeutics Limited (ASX:CYV)

Ceryvyn Therapeutics Revenue

In the fiscal year ending June 30, 2026, Ceryvyn Therapeutics had annual revenue of 1.00K AUD, down -99.56%.

• Revenue: 1.00K
• Revenue Growth: -99.56%
• P/S Ratio: 13,679.78
• Revenue / Employee: 30.30
• Employees: 33
• Market Cap: 13.68M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	1.00K	-227.00K	-99.56%
Jun 30, 2025	228.00K	-164.69K	-41.94%
Jun 30, 2024	392.69K	-186.19K	-32.16%
Jun 30, 2023	578.88K	290.04K	100.42%
Jun 30, 2022	288.84K	161.37K	126.61%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 13, 2026

Data Sources Report a data error